Home › Funds › Velan Capital Investment Management LP › IMMX
Velan Capital Investment Management LP position in IMMX
IMMIX BIOPHARMA INC · Health Care
Velan Capital Investment Management LP reported holding 1,085,000 shares of IMMX (IMMIX BIOPHARMA INC) in its Q3 2026 13F filing — a position valued at US$11.3M, representing 10.78% of its reported portfolio and ranking #2 among its reported holdings. Velan Capital Investment Management LP has disclosed IMMX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Velan Capital Investment Management LP's IMMX position evolved
Velan Capital Investment Management LP first disclosed a stake in IMMX in Q2 2025 at 25,000 shares (US$52K). The position peaked in Q3 2026 at 1,085,000 shares, worth US$11.3M. Across 6 filings, Velan Capital Investment Management LP increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 1,085,000 shares valued at US$11.3M. Notable position changes include a 40% increase in Q3 2025 (shares rose 150% over the following quarter), a 2014% increase in Q1 2026 (shares rose 13% over the following quarter), a 47% increase in Q2 2026 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 25.00K | $51.75K | New |
| Q3 2025 | 35.00K | $73.15K | Add |
| Q4 2025 | 35.00K | $183.05K | Hold |
| Q1 2026 | 740.00K | $6.74M | Add |
| Q2 2026 | 1.08M | $11.19M | Add |
| Q3 2026 | 1.08M | $11.29M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMMX and 13F data
IMMX (IMMIX BIOPHARMA INC) is a Health Care company. 93 other funds we track also report a position in IMMX — the largest reported positions include EVENTIDE ASSET MANAGEMENT, LLC (US$54.0M), Saturn V Capital Management LP (US$48.5M), Opaleye Management Inc. (US$24.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMMX
- EVENTIDE ASSET MANAGEMENT, LLC 5.19M sh · $53.97M · Q3 2026
- Saturn V Capital Management LP 4.66M sh · $48.50M · Q3 2026
- Opaleye Management Inc. 2.35M sh · $24.18M · Q2 2026
- GREAT POINT PARTNERS LLC 1.28M sh · $13.17M · Q2 2026
- Bleichroeder LP 1.00M sh · $10.40M · Q3 2026
- Blue Owl Capital Holdings LP 602.05K sh · $6.26M · Q3 2026
- Monashee Investment Management LLC 450.00K sh · $4.68M · Q3 2026
- KVP Capital Advisors, LP 230.42K sh · $2.40M · Q3 2026
- Imprint Wealth LLC 20.94K sh · $217.86K · Q3 2026
More on Velan Capital Investment Management LP
FAQ
How long has Velan Capital Investment Management LP held IMMX?
Velan Capital Investment Management LP has disclosed IMMX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is Velan Capital Investment Management LP's current position in IMMX?
As of Q3 2026, Velan Capital Investment Management LP holds 1.08M shares of IMMX (IMMIX BIOPHARMA INC), valued at $11.29M, representing 10.78% of its reported portfolio and ranking #2.
Has Velan Capital Investment Management LP been buying or selling IMMX?
In the latest 13F filing (Q3 2026), Velan Capital Investment Management LP held unchanged its position in IMMX. The position peaked in Q3 2026 at 1.08M shares.
Which other funds hold IMMX?
Other major institutional holders of IMMX include EVENTIDE ASSET MANAGEMENT, LLC, Saturn V Capital Management LP, Opaleye Management Inc., among 93 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.